help button home button Am J Pathol R & D Systems
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Purchase Article
Right arrow View Shopping Cart
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Chen, G. G.
Right arrow Articles by Li, A. K. C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Chen, G. G.
Right arrow Articles by Li, A. K. C.
(American Journal of Pathology. 2003;162:1823-1829.)
© 2003 American Society for Investigative Pathology

Mutation of p53 in Recurrent Hepatocellular Carcinoma and Its Association with the Expression of ZBP-89

George G. Chen*{dagger}, Juanita L. Merchant{ddagger}§, Paul B. S. Lai*, Rocky L. K. Ho*, Xu Hu*, Morihiro Okada{ddagger}, Sheng F. Huang*||, Albert K. K. Chui*, David J. Law, Yong G. Li||, Wan Y. Lau* and Arthur K. C. Li*

From the Department of Surgery* and the Sir Y. K. Pao Center for Cancer,{dagger} Prince of Wales Hospital, The Chinese University of Hong Kong, Shatin, N.T., Hong Kong; the Departments of Internal Medicine{ddagger} and Physiology§ and the Howard Hughes Medical Institute, University of Michigan, Ann Arbor, Michigan; and the Department of Surgery,|| The Second Affiliated Hospital, Xiang Ya Medical School, Changsha, Hunan, China

p53 has recently been identified as a downstream target of ZBP-89, a zinc finger transcription factor. ZBP-89 promotes growth arrest through stabilization of the p53 protein. The aim of this study is to determine the status of the p53 gene in recurrent human hepatocellular carcinoma (HCC) and test the link between the expression of ZBP-89 and the p53 gene. The results showed that mutations in the p53 gene were frequently detected in recurrent HCC. The interval between surgical resection and the recurrence of HCC was significantly longer in patients with the wild-type p53 gene than those with mutations, strongly suggesting a pathological role for the mutant p53 gene in HCC recurrence. Among those positive for the p53 protein, nearly 85% (18 of 21) showed nuclear localization of the p53 protein while only about 14% (3 of 21) were positive for the p53 protein in the cytoplasm. ZBP-89 co-localized with p53 in the nucleus in about 67% (12 of 18) of all cases positive for the nuclear p53 protein, suggesting that ZBP-89 may play a role in the nuclear accumulation of the p53 protein in a subset of recurrent HCC. With accumulation of p53 protein in the nucleus, tumor cells undergo apoptosis and thus are more susceptible to radiotherapy and chemotherapy. Therefore, co-localization of p53 protein with ZBP-89 may define a subgroup of recurrent HCC that is more sensitive to treatment.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Gastrointest. Liver Physiol.Home page
M. S. Malo, M. Mozumder, X. B. Zhang, S. Biswas, A. Chen, L.-C. Bai, J. L. Merchant, and R. A. Hodin
Intestinal alkaline phosphatase gene expression is activated by ZBP-89
Am J Physiol Gastrointest Liver Physiol, April 1, 2006; 290(4): G737 - G746.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2003 by the American Society for Investigative Pathology.